BR132016008209F1 - NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES - Google Patents
NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USESInfo
- Publication number
- BR132016008209F1 BR132016008209F1 BR132016008209A BR132016008209A BR132016008209F1 BR 132016008209 F1 BR132016008209 F1 BR 132016008209F1 BR 132016008209 A BR132016008209 A BR 132016008209A BR 132016008209 A BR132016008209 A BR 132016008209A BR 132016008209 F1 BR132016008209 F1 BR 132016008209F1
- Authority
- BR
- Brazil
- Prior art keywords
- nanocomplexes
- nucleic acids
- delivery
- preparation
- preparation process
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
NANOCOMPLEXOS PARA ENTREGA DE ÁCIDOS NUCLÉICOS, PROCESSO DE PREPARAÇÃO E USOS. O presente documento constitui Certificado de Adição ao pedido de patente BR102013032731-0, intitulado "PROCESSO DE PREPARAÇÃO DE NANOCOMPÓSITOS FOSFATADOS BIOCOMPATÍVEIS, PRODUTOS E USOS", depositado em 19/12/2013, e refere-se a nanocomplexos para entrega de ácidos nucléicos, compreendendo nanocompósitos fosfatados (NPCs) complexados com moléculas de ácidos nucléicos, o processo de preparação de tais nanocomplexos e seu uso na entrega de ácidos nucléicos, como genes ou siRNA, a células, incluindo células de difícil transfecção, e em terapia gênica.NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES. This document constitutes a Certificate of Addition to patent application BR102013032731-0, entitled "PROCESS FOR PREPARATION OF BIOCOMPATIBLE PHOSPHATE NANOCOMPOSITES, PRODUCTS AND USES", filed on 12/19/2013, and refers to nanocomplexes for delivering nucleic acids, comprising phosphate nanocomposites (NPCs) complexed with nucleic acid molecules, the process of preparation of such nanocomplexes and their use in the delivery of nucleic acids, as genes or siRNA, to cells, including difficult to transfection cells, and in gene therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR132016008209A BR132016008209F1 (en) | 2016-04-13 | 2016-04-13 | NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR132016008209A BR132016008209F1 (en) | 2016-04-13 | 2016-04-13 | NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR132016008209E2 BR132016008209E2 (en) | 2018-06-05 |
| BR132016008209F1 true BR132016008209F1 (en) | 2023-03-21 |
Family
ID=62845824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR132016008209A BR132016008209F1 (en) | 2016-04-13 | 2016-04-13 | NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR132016008209F1 (en) |
-
2016
- 2016-04-13 BR BR132016008209A patent/BR132016008209F1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BR132016008209E2 (en) | 2018-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7235702B2 (en) | Methods and products for nucleic acid production and delivery | |
| Hao et al. | Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo | |
| MX2021005389A (en) | Lipid nanoparticle formulations. | |
| BR112016013516A8 (en) | transfection complex and its use to increase charge molecule transport in cells and for the treatment of cancer and gene therapy, as well as an in vitro method for delivering a polyanion to a cell | |
| MX2019011215A (en) | Nucleic acids encoding crispr-associated proteins and uses thereof. | |
| EP4180526A3 (en) | Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof | |
| BR112016028023A2 (en) | COMPOSITIONS AND METHODS OF ADMINISTRATION OF TREATMENTS FOR LATENT VIRAL INFECTIONS | |
| FI3445388T3 (en) | Materials and methods for treatment of hemoglobinopathies | |
| JP6595071B2 (en) | Double-stranded ribonucleic acid for adjuvant | |
| BR112018069944A2 (en) | RNA construct and methods of using it to improve therapeutic effects of cytotoxic cells and stem cells | |
| MX2017004039A (en) | Galnac phosphoramidites, nucleic acid conjugates thereof and their use. | |
| BR112015022507A2 (en) | 4'-thio-modified nucleotide ribonucleic acids, composition comprising the same and related uses | |
| WO2016061232A3 (en) | Multiplexed shrnas and uses thereof | |
| BR112016023004A2 (en) | sirna, double-stranded oligo rna structure, nanoparticle, pharmaceutical composition and lyophilized structure to prevent or treat fibrosis or respiratory diseases containing the same | |
| TR201820102T4 (en) | Fabri disease gene therapy. | |
| BR112014012600A2 (en) | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications | |
| MX2015011393A (en) | Modified poly(beta-amino ester)s for drug delivery. | |
| BR112019008810A2 (en) | 5-halouracil modified microplates and their use in cancer treatment | |
| BR112016014162A2 (en) | use of a conjugate, conjugate and methods for making a conjugate and for transfecting a cell | |
| WO2011150127A3 (en) | Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells | |
| AU2012358181A8 (en) | Compositions and methods for the delivery of biologically active RNAs | |
| BR112022002690A2 (en) | EXTRACELLULAR ASO VESICLE CONSTRUCTS TARGETING CEBP/BETA | |
| Chandler et al. | Expanding structural space for immunomodulatory nucleic acid nanoparticles via spatial arrangement of their therapeutic moieties | |
| Suryawanshi et al. | A simple alternative to stereotactic injection for brain specific knockdown of miRNA | |
| BR132016008209F1 (en) | NANOCOMPLEXES FOR DELIVERY OF NUCLEIC ACIDS, PREPARATION PROCESS AND USES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11N | Dismissal: publication cancelled [chapter 11.14 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C01B 25/26 , B82B 3/00 , B82B 1/00 , B82Y 5/00 Ipc: C01B 25/26 (2006.01), B82B 3/00 (2006.01), B82B 1/ |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2013, OBSERVADAS AS CONDICOES LEGAIS |